Avon US Files for Bankruptcy & Crown Laboratories Buys Revance Therapeutics

It’s What You’re Reading on Happi.com for the week ended August 17, 2024.

The most-viewed news on our site last week.

More bad news for Avon Products was the most-read news on our site last week. The one-time beauty direct sales leader filed for bankruptcy protection in the US. That news topped Crown Laboratories’ purchase of Revance Therapeutics.

Here are the top 10 most-viewed news items on Happi.com last week.

  1. Avon Products’ US Business Files for Bankruptcy Protection

2. Crown Laboratories To Acquire Revance Therapeutics in $924 Million Merger Deal

3. Dyson Launches Styling Products

4. Bemotrizinol Moves Closer to US FDA Approval

5. Micro-Peptide Technology Fuels Neutrogena’s New Collagen Bank Range

6. Ariana Grande Partners with Luxe Brands to Expand Fragrance Portfolio

7. Merit Expands Skincare Portfolio with Great Skin Priming Moisturizer

8. Podcast Hosts Hannah Berner and Paige DeSorbo of Giggly Squad Appear in New Lancôme Campaign

9. Top Makeup Colors for Fall 2024 Feature Warm Tones & Neutrals

10. Kosas and Naturium Lead Fastest-Growing Lip Care Brands: Spate

Keep Up With Our Content. Subscribe To Happi Newsletters